ストックスクリーナーアプリを入手
0.6641
12.75%
0.0751
アフターアワーズ：
.61
-0.0541
-8.15%
前日終値:
$0.589
開ける：
$0.5655
24時間の取引高:
9.14M
Relative Volume:
48.53
時価総額：
$23.12M
収益：
-
当期純損益:
$-82.19M
株価収益率:
-0.173
EPS:
-3.839
ネットキャッシュフロー:
$-8.35M
1週間 パフォーマンス:
-1.76%
1か月 パフォーマンス:
-3.75%
6か月 パフォーマンス:
-48.92%
1年 パフォーマンス:
+11.74%
1日の値動き範囲:
$0.4603
$0.7174
1週間の範囲:
$0.4603
$0.7174
52週間の値動き範囲:
$0.4603
$7.79
Ocean Biomedical Inc Stock (OCEA) Company Profile
名前
Ocean Biomedical Inc
セクター
電話
(646) 908-2658
住所
515 MADISON AVE SUITE 8078, NEW YORK
OCEA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.6641 | 23.12M | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ocean Biomedical Inc (OCEA) 最新ニュース
Ocean Biomedical stock hits 52-week low at $0.51 - Investing.com
Ocean Biomedical appoints new auditing firm - Investing.com
Ocean Biomedical appoints new auditing firm By Investing.com - Investing.com UK
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
Ocean Biomedical faces Nasdaq delisting over market value - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Ocean Biomedical dismisses Deloitte as certifying accountant - Investing.com
Ocean Biomedical dismisses Deloitte as certifying accountant By Investing.com - Investing.com Nigeria
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in November - Defense World
Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com
Ocean Biomedical faces Nasdaq delisting - Providence Business News
Ocean Biomedical Inc Com (OCEA) reports earnings - Quartzy
Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment - EIN News
BW LPG takes delivery of vessel BW Capella - MSN
Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL) - MSN
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Ocean Biomedical appoints interim CEO amid executive shift - Investing.com India
Ocean Biomedical appoints interim CEO amid executive shift By Investing.com - Investing.com South Africa
Ocean Biomedical receives Nasdaq’s delisting letter - MSN
Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter - GlobeNewswire
Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024 - healthcare-in-europe.com
Ocean Biomedical secures 22% Virion stake with $9 million deal - Investing.com India
Ocean Biomedical secures 22% Virion stake with $9 million deal By Investing.com - Investing.com South Africa
Molecure inks $32 million deal with Ocean Biomedical for cancer therapy - Investing.com India
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. - The Manila Times
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company - GlobeNewswire
Molecure S.A. and Ocean Biomedical Inc. Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 inhibitors - Marketscreener.com
CAE Inc. (CAE): An Undervalued Foreign Stock to Buy According to Analysts - Yahoo Finance UK
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of September 2024 - EIN News
Casella Waste Systems, Inc. to Host Conference Call on Its Third Quarter 2024 Results - EIN News
Kaltura to Announce Financial Results for Third Quarter 2024 on Wednesday, November 6, 2024 - EIN News
Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your - EIN News
Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors – Contact Levi & - EIN News
DOMINO’S PIZZA, INC. (NYSE: DPZ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Domino’s Pizza, Inc. Investors - EIN News
BioPhotonics Conference 2024 - Photonics Spectra
Ocean Biomedical Inc (OCEA) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):